"10.1371_journal.pmed.1001760","plos medicine","2014-11-25T00:00:00Z","Helen S Cox; Slindile Mbhele; Neisha Mohess; Andrew Whitelaw; Odelia Muller; Widaad Zemanay; Francesca Little; Virginia Azevedo; John Simpson; Catharina C Boehme; Mark P Nicol","Division of Medical Microbiology and Institute for Infectious Diseases and Molecular Medicine, University of Cape Town, Cape Town, South Africa; Médecins Sans Frontières, Khayelitsha, South Africa; Division of Medical Microbiology, University of Cape Town, Cape Town, South Africa; National Health Laboratory Service, Johannesburg, South Africa; Department of Statistical Science, University of Cape Town, Cape Town, South Africa; Khayelitsha Health, City of Cape Town, Cape Town, South Africa; Foundation for Innovative New Diagnostics, Geneva, Switzerland","Conceived and designed the experiments: HSC MPN. Performed the experiments: HSC SM NM AW OM WZ VA J MPN. Analyzed the data: HSC SM FL MPN. Contributed reagents/materials/analysis tools: CCB. Wrote the first draft of the manuscript: HSC. Wrote the paper: HSC SM NM AW OM WZ FL VA JS CCB MPN. ICMJE criteria for authorship read and met: HSC SM NM AW OM WZ FL VA JS CCB MPN. Agree with manuscript results and conclusions: HSC SM NM AW OM WZ FL VA JS CCB MPN. Enrolled patients: NM.","CCB is employed by the Foundation for Innovative New Diagnostics (FIND, Geneva, Switzerland), a non-profit organisation that collaborates with industry partners, including Cepheid (Sunnyvale, CA, USA), the developer of Xpert, on the development, assessment, and demonstration of new diagnostic tests. All other authors declare no competing interests. No commercial partner was involved in the study.","2014","11","Helen S Cox","HSC",11,FALSE,2,9,4,1,TRUE,TRUE,FALSE,0,NA,FALSE
